“Cancer
Services Market: Global Demand Analysis, Growth & Opportunity Outlook 2023”
The global cancer services market
is segmented into services such preventive care services, diagnostic care
services and treatment care services. Among these segments, treatment care
services segment is expected to occupy top position in overall cancer services
market during the forecast period. However, preventive care services segment is
expected to grow at highest CAGR during the forecast period. Government
initiatives’ regarding preventive vaccination in preteen boys and girls is the
key factor behind the rapid growth of cancer preventive care services segment.
Global cancer services market
is expected to flourish at a CAGR of 17.2% during the forecast period. Moreover,
the global cancer services market is expected to garner noteworthy revenue by
the end of 2023. Factors such as rising prevalence of cancer, enhancement in
healthcare infrastructure, favorable government policies are expected to intensify
the growth of the global cancer services market.
North America captured largest
market share of cancer services in 2016. Further, North America is projected to
continue its dominance over the forecast period. Rising healthcare expenditure
coupled with increasing prevalence of cancer in the region is the dynamic
factor behind the growth of cancer
services market. Further, favorable government policies and
programs in the region are likely to accelerate the growth of cancer services
market. Asia Pacific is expected to witness lucrative growth in cancer services
market during the forecast period. Increasing prevalence of cancer and rising
awareness about diagnosis and treatment are expected to bolster the growth of cancer
services market in Asia Pacific region.
Increased Prevalence of Cancer
Growing number of new cases
of cancer is major factor behind the growth of cancer services market. According
to World Health Organization, number of cancer cases is expected to increase
from 14 million in 2012 to 21 million in 2020. As a result, the demand for cancer diagnosis
and therapies is also expected to increase during the forecast period. Further,
rising awareness about early prevention of cancer is expected to intensify the
growth of cancer preventive care services.
Technological Innovation and Advancements
Advances in technologies such
as development of advanced diagnostic equipment are expected to impel the growth
of cancer services market. Moreover, heavy investment in research and
development of cancer services is anticipated to accelerate the growth of cancer
services market during the forecast period.
However, high cost of cancer treatment
and scarcity of developed healthcare infrastructure in undeveloped regions are
some of the factors which are likely to inhibit the growth of the global cancer
services market in the near future.
The
report titled “Cancer
Services Market: Global Demand Analysis, Growth & Opportunity Outlook 2023” delivers detailed overview of
the global cancer services market in terms of market segmentation by services,
by application, by end user and by region.
Further,
for the in-depth analysis, the report encompasses the industry growth drivers,
restraints, supply and demand risk, market attractiveness, BPS analysis and
Porter’s five force model.
This report also provides the
existing competitive scenario of some of the key players of the global cancer
services market which includes company profiling of GE Healthcare, Siemens
Healthcare Pvt. Ltd., Philips Healthcare, Abbott Diagnostics, Eli Lilly and
Company, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi and Merck
& Co. The profiling enfolds key
information of the companies which encompasses business overview, products and
services, key financials and recent news and developments. On the whole, the
report depicts detailed overview of the global cancer services market that will
help industry consultants, equipment manufacturers, existing players searching
for expansion opportunities, new players searching possibilities and other
stakeholders to align their market centric strategies according to the ongoing
and expected trends in the future.
About Research
Nester
Research Nester is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision so as to avoid future uncertainties.
Read more Information: https://www.researchnester.com/reports/cancer-services-market-global-demand-analysis-growth-opportunity-outlook-2023/227
Contact for more
Info:
Ajay
Daniel
U.S.
+1 646 586 9123
U.K.
+44 203 608 5919
No comments:
Post a Comment